BioTech (Shanghai) Chairman Jim Wu attended the 2025 Heartland Connect for Trade & Investment Conference, hosted by USHCA, engaging leaders from Mayo Clinic’s DMC and U.S. healthcare organizations. The event fostered dialogue on AI, healthcare access, and innovation, advancing U.S.–China collaboration and helping Chinese MedTech firms enter the American market.

In this interview, Jim Wu, founder of SaniMed, shares insights on medical device investment, clinical research, and strategic partnerships.